Cargando…
Immunotherapy of melanoma
Melanoma is considered one of the immunogenic – if not the most immunogenic – malignancies. This is based on several observations. 1. Spontaneous remissions occur occasionally. 2. In about 5% of melanomas no primary tumour is found. The genetic aberrations of these tumours closely resemble those of...
Autor principal: | Haanen, John B.A.G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4041176/ https://www.ncbi.nlm.nih.gov/pubmed/26217118 http://dx.doi.org/10.1016/j.ejcsup.2013.07.013 |
Ejemplares similares
-
Novel strategies to improve efficacy of treatment with tumor-infiltrating lymphocytes (TILs) for patients with solid cancers
por: Tas, Liselotte, et al.
Publicado: (2023) -
Advances in immunotherapy for melanoma
por: Redman, Jason M., et al.
Publicado: (2016) -
Melanoma immunotherapy
por: Garg, Abhishek D., et al.
Publicado: (2015) -
Immunotherapy of melanoma
por: Lugowska, Iwona, et al.
Publicado: (2018) -
Selective Expansion of Cross-Reactive Cd8(+) Memory T Cells by Viral Variants
por: Haanen, John B.A.G., et al.
Publicado: (1999)